Algert Global’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,669
| Closed | -$140K | – | 1160 |
|
|
2022
Q2 | $140K | Sell |
11,669
-13,798
| -54% | -$166K | 0.01% | 1074 |
|
|
2022
Q1 | $334K | Buy |
25,467
+9,222
| +57% | +$121K | 0.02% | 939 |
|
|
2021
Q4 | $286K | Sell |
16,245
-6,904
| -30% | -$122K | 0.04% | 745 |
|
|
2021
Q3 | $502K | Buy |
23,149
+14,934
| +182% | +$324K | 0.07% | 536 |
|
|
2021
Q2 | $288K | Buy |
8,215
+1,005
| +14% | +$35.2K | 0.1% | 294 |
|
|
2021
Q1 | $711K | Sell |
7,210
-5,556
| -44% | -$548K | 0.23% | 158 |
|
|
2020
Q4 | $1.38M | Buy |
12,766
+3,679
| +40% | +$399K | 0.39% | 84 |
|
|
2020
Q3 | $936K | Buy |
9,087
+6,094
| +204% | +$628K | 0.3% | 135 |
|
|
2020
Q2 | $625K | Hold |
2,993
| – | – | 0.21% | 155 |
|
|
2020
Q1 | $292K | Buy |
+2,993
| New | +$292K | 0.12% | 253 |
|
|
2019
Q3 | – | Sell |
-2,536
| Closed | -$302K | – | 360 |
|
|
2019
Q2 | $302K | Buy |
+2,536
| New | +$302K | 0.11% | 224 |
|
|
2019
Q1 | – | Sell |
-9,411
| Closed | -$296K | – | 300 |
|
|
2018
Q4 | $296K | Buy |
9,411
+1,465
| +18% | +$46.1K | 0.08% | 284 |
|
|
2018
Q3 | $481K | Sell |
7,946
-285
| -3% | -$17.3K | 0.1% | 252 |
|
|
2018
Q2 | $436K | Buy |
8,231
+933
| +13% | +$49.4K | 0.09% | 253 |
|
|
2018
Q1 | $423K | Buy |
+7,298
| New | +$423K | 0.08% | 266 |
|